Business
Moderna shares Covid-19 vaccine trial blueprints, Pfizer follows – Bangkok Post
WASHINGTON: US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency.
WASHINGTON: US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency.
Pfizer, the other American company currently carrying out Phase 3 trials in the US, followed suit a short time later and there is now added pressure for the remainder to do the same.
Phase 3 is the final stage before approval, in which a vaccine and a placebo are tested…
-
Business20 hours agoBroker names 2 small cap ASX shares to buy for big returns
-
Noosa News20 hours agoMin Woo Lee, Adam Scott and Cameron Smith in the mix after Australian PGA opening round in Brisbane
-
Business20 hours agoThese top ASX 200 stocks could rise 25% to 60%
-
Noosa News20 hours agoDid AI write your accounting expert’s report? – Proctor